Literature DB >> 29189379

Impact of Surgical Margin Width on Recurrence and Overall Survival Following R0 Hepatic Resection of Colorectal Metastases: A Systematic Review and Meta-analysis.

Georgios A Margonis1, Theodoros N Sergentanis2, Ioannis Ntanasis-Stathopoulos2, Nikolaos Andreatos1, Ioannis-Georgios Tzanninis2, Kazunari Sasaki1, Theodora Psaltopoulou2, Jaeyun Wang1, Stefan Buettner1, Αpostolos E Papalois3, Jin He1, Christopher L Wolfgang1, Timothy M Pawlik4, Matthew J Weiss1.   

Abstract

OBJECTIVE: To examine the impact of surgical margin width on survival following R0 hepatic resection for colorectal metastases (CRLM). SUMMARY OF BACKGROUND DATA: Although negative resection margin is considered of paramount importance for the prognosis of patients with colorectal liver metastases, optimal resection margin width remains controversial.
METHODS: Eligible studies examining the association between margin status after R0 hepatic resection for CRLM and survival, including overall survival (OS) and disease-free survival (DFS) were sought using the Medline, Cochrane, and EMBASE databases. Random-effects models were used for the calculation of pooled relative risks (RRs) with their 95% confidence intervals (95% CIs).
RESULTS: Thirty-four studies were deemed eligible for inclusion representing a cohort of 11,147 hepatic resections. Wider resection margin (>1 vs <1 cm) was significantly associated with improved OS at 3 years (pooled RR = 0.86, 95% CI: 0.79-0.95), 5 years (pooled RR = 0.91, 95% CI: 0.85-0.97), and 10 years (pooled RR = 0.94, 95% CI: 0.88-1.00). Similarly, DFS was positively associated with >1 cm resection margin at 3, 5, and 10 years. Interestingly, >1 mm (vs <1 mm) resection margin was significantly associated with improved OS at all-time points. Meta-regression analyses did not reveal any significant modifying role of the study features under investigation, such as the administration of neoadjuvant/adjuvant therapy.
CONCLUSIONS: Importantly, our findings suggest that while a >1 mm margin is associated with better prognosis than a submillimeter margin, achieving a margin >1 cm may result in even better oncologic outcomes and should be considered if possible.

Entities:  

Mesh:

Year:  2018        PMID: 29189379     DOI: 10.1097/SLA.0000000000002552

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  21 in total

1.  Histopathological growth patterns and positive margins after resection of colorectal liver metastases.

Authors:  Pieter M H Nierop; Diederik J Höppener; Eric P van der Stok; Boris Galjart; Florian E Buisman; Vinod P Balachandran; William R Jarnagin; T Peter Kingham; Peter J Allen; Jinru Shia; Peter B Vermeulen; Bas Groot Koerkamp; Dirk J Grünhagen; Cornelis Verhoef; Michael I D'Angelica
Journal:  HPB (Oxford)       Date:  2019-11-15       Impact factor: 3.647

2.  Minimally invasive treatment of colorectal liver metastases: does robotic surgery provide any technical advantages over laparoscopy? A multicenter analysis from the IGoMILS (Italian Group of Minimally Invasive Liver Surgery) registry.

Authors:  Michele Masetti; Guido Fallani; Luca Aldrighetti; Elio Jovine; Francesca Ratti; Alessandro Ferrero; Felice Giuliante; Umberto Cillo; Alfredo Guglielmi; Giuseppe Maria Ettorre; Guido Torzilli; Leonardo Vincenti; Giorgio Ercolani; Chiara Cipressi; Raffaele Lombardi
Journal:  Updates Surg       Date:  2022-01-31

3.  One- versus two-stage partial hepatectomy for large resectable solitary hepatocellular carcinomas determined preoperatively to have a narrow resection margin: a propensity score matching analysis.

Authors:  Yao Li; Peng-Peng Li; Da-Peng Sun; Jun-Sheng Ni; Wan Yee Lau; Gang Huang; Wei-Ping Zhou; Hui Liu; Ze-Ya Pan; Yuan Yang; Ling-Hao Zhao
Journal:  Hepatobiliary Surg Nutr       Date:  2022-10       Impact factor: 8.265

4.  PRIMARY TUMOR LYMPHOVASCULAR INVASION NEGATIVELY AFFECTS SURVIVAL AFTER COLORECTAL LIVER METASTASIS RESECTION?

Authors:  Renato Gomes Campanati; João Bernardo Sancio; Lucas Mauro de Andrade Sucena; Marcelo Dias Sanches; Vivian Resende
Journal:  Arq Bras Cir Dig       Date:  2021-06-11

Review 5.  Hepatic metastasis from colorectal cancer.

Authors:  Alfred Wei Chieh Kow
Journal:  J Gastrointest Oncol       Date:  2019-12

Review 6.  Current status of surgical treatment of colorectal liver metastases.

Authors:  Feng Xu; Bin Tang; Tian-Qiang Jin; Chao-Liu Dai
Journal:  World J Clin Cases       Date:  2018-11-26       Impact factor: 1.337

Review 7.  Multidisciplinary approach of liver metastases from colorectal cancer.

Authors:  René Adam; Yuki Kitano
Journal:  Ann Gastroenterol Surg       Date:  2019-01-14

8.  Parenchymal-sparing versus extended hepatectomy for colorectal liver metastases: A systematic review and meta-analysis.

Authors:  Gang Deng; Hui Li; Gui-Qing Jia; Dan Fang; You-Yin Tang; Jie Xie; Ke-Fei Chen; Zhe-Yu Chen
Journal:  Cancer Med       Date:  2019-08-28       Impact factor: 4.452

9.  Retrospective cohort study of statin therapy effect on resected colorectal liver metastases.

Authors:  Edward Alabraba; Hussain Ibrahim; Adina Olaru; Iain Cameron; Dhanny Gomez; Nottingham Hpb Surgery Group
Journal:  World J Gastrointest Surg       Date:  2020-02-27

Review 10.  Simultaneous curative resection of double colorectal carcinoma with synchronous bilobar liver metastases.

Authors:  Emilio De Raffele; Mariateresa Mirarchi; Dajana Cuicchi; Ferdinando Lecce; Claudio Ricci; Riccardo Casadei; Bruno Cola; Francesco Minni
Journal:  World J Gastrointest Oncol       Date:  2018-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.